CDMO will perform HQ plasmid production in support of Phase I/II clinical trials for Infantile Neuroaxonal DystrophyALDERLEY PARK, England (BUSINESS WIRE) Charles River Laboratories International, Inc. (NYSE: CRL) and the INADcure Foundation, a nonprofit organization whose mission is to support the development of.
Charles River Laboratories (CRL) and INADcure Announce Gene Therapy Manufacturing Collaboration streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CDMO will perform HQ plasmid production in support of Phase I/II clinical trials for Infantile Neuroaxonal Dystrophy Charles River Laboratories International, Inc. (NYSE: CRL) and the INADcure Foundation